Trial record 5 of 218 for:    Open Studies | "Mycobacterium Infections"

Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2012 by China Medical University Hospital
Sponsor:
Information provided by (Responsible Party):
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT01628744
First received: June 24, 2012
Last updated: June 26, 2012
Last verified: June 2012
  Purpose

In adult, the prevalence of mycobacterial infections is increased with age is largely unknown. IFN-gamma-IL-12/23 axis or NF-kappaB pathways might also plays crucial roles in adult against mycobacteria. Based on this hypothesis, the investigators had applied a functional assay to these pathways in patients with mycobacterial infection.


Condition
Mycobacterium Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by China Medical University Hospital:

Estimated Enrollment: 100
Study Start Date: January 2011
Estimated Study Completion Date: December 2014
Groups/Cohorts
Patients with mycobacterial infection

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Pateitns with Mycobacterium, Particular to the non Tuberculosis mycobacterium infection, in Taiwan

Criteria

Inclusion Criteria:

  • Patients with mycobacterial infection

Exclusion Criteria:

  • Malignancy
  • Severe autoimmune
  • HIV infection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01628744

Contacts
Contact: Cheng-?Lung KU, Ph.D (886) (0)3 211-8800 ext 3496 clku@mail.cgu.edu.tw

Locations
Taiwan
Graduate Institute of Clinical Medical Science, China Medical University Recruiting
Taichung, Taiwan
Principal Investigator: Chih Y. Chi, M.D,         
Sponsors and Collaborators
China Medical University Hospital
Investigators
Principal Investigator: Cheng-Lung KU, Ph.D Graduate Institute of clinical Medical Science, China Medical Univerity, Taiwan
  More Information

No publications provided

Responsible Party: China Medical University Hospital
ClinicalTrials.gov Identifier: NCT01628744     History of Changes
Other Study ID Numbers: DMR-99-IRB-075-1
Study First Received: June 24, 2012
Last Updated: June 26, 2012
Health Authority: Taiwan: Department of Health

Additional relevant MeSH terms:
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on July 24, 2014